Childrens Hosp Pittsburgh UPMC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 11 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Recruiting

  Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

  NCT06751238· Phase 1· Novartis Pharmaceuticals· Source

  Contact: Vibha Chauhan

• Recruiting

  Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

  NCT05948943· Phase 2/3· Novartis Pharmaceuticals· Source

  Contact: Alex Berkebile

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriatic arthritis1 recruiting

Closed trials

• Recruiting

  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  NCT05682378· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals